» Articles » PMID: 30870183

Endocrine and Reproductive Profile of Boys and Young Adults Conceived After ICSI

Overview
Date 2019 Mar 15
PMID 30870183
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: The impact of intracytoplasmic sperm injection (ICSI), on the reproductive health of the offspring is largely unknown. Here we provide a comprehensive overview of the endocrine and reproductive profile in boys and young male adults born after ICSI using ejaculated spermatozoa alleviating male factor infertility in their parents.

Recent Findings: Levels of testosterone, anti-Müllerian hormone and inhibin B were found comparable in prepubertal and pubertal boys conceived by ICSI when compared with levels in boys conceived spontaneously. Also, at young adulthood, mean levels of reproductive hormones did not differ from control peers. However, semen analysis showed significantly lower sperm concentration, total sperm count and total motile sperm count when compared with controls. Furthermore, the risk of having sperm concentration and sperm count below the reference values was increased in ICSI offspring while sperm parameters did not correlate in paired father-son semen analysis.

Summary: Although endocrine gonadal function was normal at puberty, exocrine function at young adulthood was not. We observed decreased semen quality and quantity in young adults conceived by ICSI performed to circumvent male factor infertility. The possibility of transgenerational transmission of impaired spermatogenesis after ICSI needs further investigation.

Citing Articles

Reproductive outcomes in women and men conceived by assisted reproductive technologies in Norway: prospective registry based study.

Carlsen E, Wilcox A, Magnus M, Hanevik H, Haberg S BMJ Med. 2023; 2(1):e000318.

PMID: 37051028 PMC: 10083741. DOI: 10.1136/bmjmed-2022-000318.


Intracytoplasmic Sperm Injection May Not Improve Clinical Outcomes Despite Its Positive Effect on Embryo Results: A Retrospective Analysis of 1130 Half-ICSI Treatments.

Peng N, Ma S, Li C, Liu H, Zhao H, Li L Front Endocrinol (Lausanne). 2022; 13:877471.

PMID: 35784567 PMC: 9240197. DOI: 10.3389/fendo.2022.877471.


The Consequences of Assisted Reproduction Technologies on the Offspring Health Throughout Life: A Placental Contribution.

Schroeder M, Badini G, Sferruzzi-Perri A, Albrecht C Front Cell Dev Biol. 2022; 10:906240.

PMID: 35747691 PMC: 9210138. DOI: 10.3389/fcell.2022.906240.


Oocyte activation deficiency and assisted oocyte activation: mechanisms, obstacles and prospects for clinical application.

Kashir J, Ganesh D, Jones C, Coward K Hum Reprod Open. 2022; 2022(2):hoac003.

PMID: 35261925 PMC: 8894871. DOI: 10.1093/hropen/hoac003.


IVF or ICSI for fertility preservation?.

Aggarwal B, Evans A, Ryan H, Martins da Silva S Reprod Fertil. 2022; 2(1):L1-L3.

PMID: 35128437 PMC: 8812449. DOI: 10.1530/RAF-20-0059.